{
  "id": "CKD_GFRMonitoringFrequency.v11",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2019-10-31",
      "name": "Jacques BOUAUD",
      "organisation": "AP-HP - LIMICS",
      "email": "jacques.bouaud@aphp.fr"
    },
    "other_contributors": [
      "Jacques BOUAUD",
      "Brigitte SEROUSSI",
      "Catherine DUCLOS"
    ],
    "lifecycle_state": "Author draft",
    "details": {
      "sv": {
        "id": "sv",
        "purpose": "To determine the frequency of GFR control per year.",
        "keywords": [
          "C3-Cloud",
          "Chronic Kidney Disease",
          "Renal Failure",
          "GFR monitoring frequency",
          "Version 11"
        ],
        "misuse": "Implementation notes [03/06/2019 JB]\n- All rules implemented\n- No specific profile used\n- Execution in the GDL2 editor works for all rules\n- Two reconciliation rules added: R2.4-5.DM-RF7-11 and R2.6-8.DM-RF8-12.\n- Corrections of trailing whitespaces in LOINC codes\n- [10/01/2019: prepared multilingual support (en/sv/es)]\n- [11/01/2019: adaptation to GDL2 Editor v2.3.0 - max(effectiveDateTime)]\n- [24/01/2019: include full mappings for CDSM terminologies]\n- [25/01/2019: include validated translations for Swedish and Spanish]\n- [30/01/2019: include codes for local terminologies]\n- [20/02/2019: Correction for READ2 and ICD-10-SE identifiers]\n- [29/05/2019: Multiple units for ACR by KK]\n- [16/09/2019: ICD-10-UK (and READ) update for CKD, HF, Diabetes and AF by JB]\n- [30/09/2019: hand-made correction for extensions by JB]\n- [21/10/2019: hand-made correction for English labels in Spanish and Swedish (#271, #274) by JB]\n- [31/10/2019: hand-made correction for glomerualr (#309) by JB]",
        "copyright": "© LIMICS"
      },
      "en": {
        "id": "en",
        "purpose": "To determine the frequency of GFR control per year.",
        "keywords": [
          "C3-Cloud",
          "Chronic Kidney Disease",
          "Renal Failure",
          "GFR monitoring frequency",
          "Version 11"
        ],
        "misuse": "Implementation notes [03/06/2019 JB]\n- All rules implemented\n- No specific profile used\n- Execution in the GDL2 editor works for all rules\n- Two reconciliation rules added: R2.4-5.DM-RF7-11 and R2.6-8.DM-RF8-12.\n- Corrections of trailing whitespaces in LOINC codes\n- [10/01/2019: prepared multilingual support (en/sv/es)]\n- [11/01/2019: adaptation to GDL2 Editor v2.3.0 - max(effectiveDateTime)]\n- [24/01/2019: include full mappings for CDSM terminologies]\n- [25/01/2019: include validated translations for Swedish and Spanish]\n- [30/01/2019: include codes for local terminologies]\n- [20/02/2019: Correction for READ2 and ICD-10-SE identifiers]\n- [29/05/2019: Multiple units for ACR by KK]\n- [16/09/2019: ICD-10-UK (and READ) update for CKD, HF, Diabetes and AF by JB]\n- [30/09/2019: hand-made correction for extensions by JB]\n- [21/10/2019: hand-made correction for English labels in Spanish and Swedish (#271, #274) by JB]\n- [31/10/2019: hand-made correction for glomerualr (#309) by JB]",
        "copyright": "© LIMICS"
      },
      "es": {
        "id": "es",
        "purpose": "To determine the frequency of GFR control per year.",
        "keywords": [
          "C3-Cloud",
          "Chronic Kidney Disease",
          "Renal Failure",
          "GFR monitoring frequency",
          "Version 11"
        ],
        "misuse": "Implementation notes [03/06/2019 JB]\n- All rules implemented\n- No specific profile used\n- Execution in the GDL2 editor works for all rules\n- Two reconciliation rules added: R2.4-5.DM-RF7-11 and R2.6-8.DM-RF8-12.\n- Corrections of trailing whitespaces in LOINC codes\n- [10/01/2019: prepared multilingual support (en/sv/es)]\n- [11/01/2019: adaptation to GDL2 Editor v2.3.0 - max(effectiveDateTime)]\n- [24/01/2019: include full mappings for CDSM terminologies]\n- [25/01/2019: include validated translations for Swedish and Spanish]\n- [30/01/2019: include codes for local terminologies]\n- [20/02/2019: Correction for READ2 and ICD-10-SE identifiers]\n- [29/05/2019: Multiple units for ACR by KK]\n- [16/09/2019: ICD-10-UK (and READ) update for CKD, HF, Diabetes and AF by JB]\n- [30/09/2019: hand-made correction for extensions by JB]\n- [21/10/2019: hand-made correction for English labels in Spanish and Swedish (#271, #274) by JB]\n- [31/10/2019: hand-made correction for glomerualr (#309) by JB]",
        "copyright": "© LIMICS"
      }
    },
    "other_details": {
      "references": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015\nhttps://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria"
    },
    "references": [
      {
        "id": "1",
        "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
        "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria"
      }
    ]
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "org.hl7.fhir.dstu3.model.Observation",
        "template_id": "FHIR-STU3-Observation.estimated_glomerular_filtration_rate.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/valueQuantity"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/code/coding[0]"
          },
          "gt0202": {
            "id": "gt0202",
            "path": "/effectiveDateTime"
          }
        },
        "predicates": [
          "/code/coding[0] is_a local::gt0005|eGFRcode|",
          "max(/effectiveDateTime)"
        ]
      },
      "gt0006": {
        "id": "gt0006",
        "model_id": "org.hl7.fhir.dstu3.model.Observation",
        "template_id": "FHIR-STU3-Observation.albumin_creatinine_ratio.v0",
        "type": "INPUT",
        "elements": {
          "gt0007": {
            "id": "gt0007",
            "path": "/valueQuantity"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/code/coding[0]"
          },
          "gt0203": {
            "id": "gt0203",
            "path": "/effectiveDateTime"
          }
        },
        "predicates": [
          "/code/coding[0] is_a local::gt0009|ACRcode|",
          "max(/effectiveDateTime)"
        ]
      },
      "gt0155": {
        "id": "gt0155",
        "model_id": "org.hl7.fhir.dstu3.model.Condition",
        "template_id": "FHIR-STU3-Condition.problem_diagnosis.v0",
        "type": "INPUT",
        "elements": {
          "gt0156": {
            "id": "gt0156",
            "path": "/code/coding[0]"
          }
        },
        "predicates": [
          "/code/coding[0] is_a local::gt0157|Diabetescode|"
        ]
      },
      "gt0199": {
        "id": "gt0199",
        "model_id": "org.hl7.fhir.dstu3.model.Condition",
        "template_id": "FHIR-STU3-Condition.problem_diagnosis.v0",
        "type": "INPUT",
        "elements": {
          "gt0200": {
            "id": "gt0200",
            "path": "/code/coding[0]"
          }
        },
        "predicates": [
          "/code/coding[0] is_a local::gt0201|CKDcode|"
        ]
      }
    },
    "templates": {
      "gt0035": {
        "id": "gt0035",
        "name": "org.hl7.fhir.dstu3.model.Appointment",
        "model_id": "org.hl7.fhir.dstu3.model.Appointment",
        "template_id": "FHIR-STU3-Appointment.generic.v0",
        "object": {
          "specialty": [
            {
              "text": "{$gt0063}"
            }
          ],
          "start": "{$gt0037}",
          "description": "{$gt0036}",
          "status": "proposed",
          "resourceType": "Appointment"
        }
      },
      "gt0046": {
        "id": "gt0046",
        "name": "org.hl7.fhir.dstu3.model.ProcedureRequest",
        "model_id": "org.hl7.fhir.dstu3.model.ProcedureRequest",
        "template_id": "FHIR-STU3-ProcedureRequest.generic.v0",
        "object": {
          "extension": [
            {
              "valueString": "EMPTY0",
              "url": "https://gitlab.cambiocds.com/CDS-PLATFORM/c3cloud-cdsm/blob/resource_profiles/src/main/resources/extensions/extension-ProcedureRequest-description-string-value.xml"
            }
          ],
          "code": {
            "coding": [
              {
                "code": "{$gt0053}",
                "system": "http://loinc.org",
                "display": "{$gt0052}"
              }
            ],
            "text": "EMPTY5"
          },
          "performer": {
            "display": "{$gt0047}"
          },
          "occurrenceTiming": {
            "code": {
              "coding": {
                "code": "{$gt0050}",
                "system": "http://snomed.info/sct",
                "display": "{$gt0048}"
              },
              "text": "{$gt0051}"
            }
          },
          "intent": "proposal",
          "status": "draft",
          "resourceType": "ProcedureRequest"
        }
      }
    },
    "pre_conditions": [
      "$gt0200|CKD|!=null"
    ],
    "rules": {
      "gt0012": {
        "id": "gt0012",
        "priority": 14,
        "when": [
          "$gt0003|eGFRValue|>=60,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|<3,mg/mmol)||($gt0007|ACRValue|<3,g/mol))||($gt0007|ACRValue|<30,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0014.term}",
            "detail": "{$gt0015.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "1653cc2d-e77f-4c73-8269-37c00a87b410",
                "label": "{$gt0038.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0055.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0204.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Once per year'",
                        "$gt0050='307455008'",
                        "$gt0051='Have eGFR measure once a year or less, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0057.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0205.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Once per year'",
                        "$gt0050='307455008'",
                        "$gt0051='Have ACR measure once a year or less, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0062.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+1,a",
                        "$gt0036=$gt0206.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0064": {
        "id": "gt0064",
        "priority": 13,
        "when": [
          "$gt0003|eGFRValue|>=60,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|>=3,mg/mmol)||($gt0007|ACRValue|>=3,g/mol))||($gt0007|ACRValue|>=30,mg/g)",
          "(($gt0007|ACRValue|<=30,mg/mmol)||($gt0007|ACRValue|<=30,g/mol))||($gt0007|ACRValue|<=300,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0065.term}",
            "detail": "{$gt0066.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "f6e2a9d5-8e00-49a5-80ea-02960f33372a",
                "label": "{$gt0067.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0068.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0207.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Once per year'",
                        "$gt0050='307455008'",
                        "$gt0051='Have eGFR measure once a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0069.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0208.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Once per year'",
                        "$gt0050='307455008'",
                        "$gt0051='Have ACR measure once a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0070.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+1,a",
                        "$gt0036=$gt0209.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0078": {
        "id": "gt0078",
        "priority": 12,
        "when": [
          "$gt0003|eGFRValue|>=60,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|>30,mg/mmol)||($gt0007|ACRValue|>30,g/mol))||($gt0007|ACRValue|>300,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0079.term}",
            "detail": "{$gt0080.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "88859c37-f09f-4a46-8cd2-ff42e15adce1",
                "label": "{$gt0081.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0082.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0210.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Once per year'",
                        "$gt0050='307455008'",
                        "$gt0051='Have eGFR measure once a year or more, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0083.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0211.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Once per year'",
                        "$gt0050='307455008'",
                        "$gt0051='Have ACR measure once a year or more, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0084.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+1,a",
                        "$gt0036=$gt0212.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0085": {
        "id": "gt0085",
        "priority": 11,
        "when": [
          "$gt0156|Diabetes|==null",
          "$gt0003|eGFRValue|>=45,mL/min/{1.73_m2}",
          "$gt0003|eGFRValue|<60,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|<=30,mg/mmol)||($gt0007|ACRValue|<=30,g/mol))||($gt0007|ACRValue|<=300,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0086.term}",
            "detail": "{$gt0087.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "c8e555ee-b12e-466f-9d80-571c49cce6c5",
                "label": "{$gt0088.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0089.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0213.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Once per year'",
                        "$gt0050='307455008'",
                        "$gt0051='Have eGFR measure once a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0090.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0214.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Once per year'",
                        "$gt0050='307455008'",
                        "$gt0051='Have ACR measure once a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0091.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+1,a",
                        "$gt0036=$gt0215.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0092": {
        "id": "gt0092",
        "priority": 10,
        "when": [
          "$gt0156|Diabetes|==null",
          "$gt0003|eGFRValue|>=45,mL/min/{1.73_m2}",
          "$gt0003|eGFRValue|<60,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|>30,mg/mmol)||($gt0007|ACRValue|>30,g/mol))||($gt0007|ACRValue|>300,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0093.term}",
            "detail": "{$gt0094.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "f8b76149-47c6-4b34-8172-1715e0674ffe",
                "label": "{$gt0095.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0096.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0216.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have eGFR measure twice a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0097.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0217.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have ACR measure twice a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0098.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+6,mo",
                        "$gt0036=$gt0218.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0158": {
        "id": "gt0158",
        "priority": 9,
        "when": [
          "$gt0156|Diabetes|!=null",
          "$gt0003|eGFRValue|>=45,mL/min/{1.73_m2}",
          "$gt0003|eGFRValue|<60,mL/min/{1.73_m2}"
        ],
        "cards": [
          {
            "summary": "{$gt0159.term}",
            "detail": "{$gt0160.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "aa639765-aba6-458f-bc1a-214f570b988b",
                "label": "{$gt0161.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0162.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0219.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have eGFR measure twice a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0163.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0220.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have ACR measure twice a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0166.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0221.term",
                        "$gt0053='17856-6'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have HbA1c measure before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0168.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+12,m",
                        "$gt0036=$gt0222.term",
                        "$gt0063='GP'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0170.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+6,m",
                        "$gt0036=$gt0223.term",
                        "$gt0063='nurse'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0099": {
        "id": "gt0099",
        "priority": 8,
        "when": [
          "$gt0156|Diabetes|==null",
          "$gt0003|eGFRValue|>=30,mL/min/{1.73_m2}",
          "$gt0003|eGFRValue|<45,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|<3,mg/mmol)||($gt0007|ACRValue|<3,g/mol))||($gt0007|ACRValue|<30,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0100.term}",
            "detail": "{$gt0101.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "1e04014e-5cc8-40d7-8e6d-45a0b19263f8",
                "label": "{$gt0102.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0103.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0224.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have eGFR measure twice a year or less, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0104.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0225.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have ACR measure twice a year or less, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0105.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+6,mo",
                        "$gt0036=$gt0226.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0106": {
        "id": "gt0106",
        "priority": 7,
        "when": [
          "$gt0156|Diabetes|==null",
          "$gt0003|eGFRValue|>=30,mL/min/{1.73_m2}",
          "$gt0003|eGFRValue|<45,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|>=3,mg/mmol)||($gt0007|ACRValue|>=3,g/mol))||($gt0007|ACRValue|>=30,mg/g)",
          "(($gt0007|ACRValue|<=30,mg/mmol)||($gt0007|ACRValue|<=30,g/mol))||($gt0007|ACRValue|<=300,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0107.term}",
            "detail": "{$gt0108.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "45ac7c8f-94fd-40b7-a1e1-7b04afbf8b33",
                "label": "{$gt0109.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0110.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0227.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have eGFR measure twice a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0111.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0228.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have ACR measure twice a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0112.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+6,mo",
                        "$gt0036=$gt0229.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0113": {
        "id": "gt0113",
        "priority": 6,
        "when": [
          "$gt0156|Diabetes|==null",
          "$gt0003|eGFRValue|>=30,mL/min/{1.73_m2}",
          "$gt0003|eGFRValue|<45,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|>30,mg/mmol)||($gt0007|ACRValue|>30,g/mol))||($gt0007|ACRValue|>300,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0114.term}",
            "detail": "{$gt0115.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "98b711c7-cfa7-4560-9ebe-bafb56f919e0",
                "label": "{$gt0116.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0117.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0230.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have eGFR measure twice a year or more, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0118.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0231.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have ACR measure twice a year or more, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0119.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+6,mo",
                        "$gt0036=$gt0232.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0171": {
        "id": "gt0171",
        "priority": 5,
        "when": [
          "$gt0156|Diabetes|!=null",
          "$gt0003|eGFRValue|>=30,mL/min/{1.73_m2}",
          "$gt0003|eGFRValue|<45,mL/min/{1.73_m2}"
        ],
        "cards": [
          {
            "summary": "{$gt0172.term}",
            "detail": "{$gt0173.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "3fc61eb6-ee71-406a-9824-a4ba9153e19a",
                "label": "{$gt0174.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0175.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0233.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have eGFR measure four times a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0176.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0234.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have ACR measure four times a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0177.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0235.term",
                        "$gt0053='17856-6'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have HbA1c measure before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0178.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+6,m",
                        "$gt0036=$gt0236.term",
                        "$gt0063='GP'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0179.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+4,m",
                        "$gt0036=$gt0237.term",
                        "$gt0063='nurse'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0120": {
        "id": "gt0120",
        "priority": 4,
        "when": [
          "$gt0003|eGFRValue|>=15,mL/min/{1.73_m2}",
          "$gt0003|eGFRValue|<30,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|<=30,mg/mmol)||($gt0007|ACRValue|<=30,g/mol))||($gt0007|ACRValue|<=300,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0121.term}",
            "detail": "{$gt0122.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "2a512e9c-003f-47a4-8b24-bf1a829638c4",
                "label": "{$gt0123.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0124.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0238.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have eGFR measure twice a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0125.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0239.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Twice per year'",
                        "$gt0050='307456009'",
                        "$gt0051='Have ACR measure twice a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0126.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+6,mo",
                        "$gt0036=$gt0240.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0127": {
        "id": "gt0127",
        "priority": 3,
        "when": [
          "$gt0003|eGFRValue|>=15,mL/min/{1.73_m2}",
          "$gt0003|eGFRValue|<30,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|>30,mg/mmol)||($gt0007|ACRValue|>30,g/mol))||($gt0007|ACRValue|>300,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0128.term}",
            "detail": "{$gt0129.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "541999f3-d635-4e8b-9767-3dd459a9f9c6",
                "label": "{$gt0130.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0131.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0241.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Three times per year'",
                        "$gt0050='307457000'",
                        "$gt0051='Have eGFR measure three times a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0132.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0242.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Three times per year'",
                        "$gt0050='307457000'",
                        "$gt0051='Have ACR measure three times a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0133.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+4,mo",
                        "$gt0036=$gt0243.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0141": {
        "id": "gt0141",
        "priority": 2,
        "when": [
          "$gt0003|eGFRValue|<15,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|<3,mg/mmol)||($gt0007|ACRValue|<3,g/mol))||($gt0007|ACRValue|<30,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0142.term}",
            "detail": "{$gt0143.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "432e4d24-99c6-4bad-ba75-eb12353ca68c",
                "label": "{$gt0144.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0145.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0244.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Four times per year'",
                        "$gt0050='307458005'",
                        "$gt0051='Have eGFR measure four times a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0146.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0245.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Four times per year'",
                        "$gt0050='307458005'",
                        "$gt0051='Have ACR measure four times a year, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0147.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+3,mo",
                        "$gt0036=$gt0246.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      "gt0148": {
        "id": "gt0148",
        "priority": 1,
        "when": [
          "$gt0003|eGFRValue|<15,mL/min/{1.73_m2}",
          "(($gt0007|ACRValue|>=3,mg/mmol)||($gt0007|ACRValue|>=3,g/mol))||($gt0007|ACRValue|>=30,mg/g)"
        ],
        "cards": [
          {
            "summary": "{$gt0149.term}",
            "detail": "{$gt0150.term}",
            "indicator": "info",
            "source": {
              "label": "Chronic kidney disease in adults: assessment and management - Clinical guideline [CG182] - Published date: July 2014 - Last updated: January 2015",
              "url": "https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#referral-criteria",
              "label_reference": "$ref[1].label",
              "url_reference": "$ref[1].url"
            },
            "suggestions": [
              {
                "uuid": "c1a4bcb5-d198-4025-ad66-992a8dc36ee8",
                "label": "{$gt0151.term}",
                "actions": [
                  {
                    "type": "create",
                    "description": "{$gt0152.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0247.term",
                        "$gt0053='33914-3'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Four times per year'",
                        "$gt0050='307458005'",
                        "$gt0051='Have eGFR measure four times a year or more, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0153.term}",
                    "resource_template": {
                      "template_id": "gt0046",
                      "assignments": [
                        "$gt0052=$gt0248.term",
                        "$gt0053='32294-1'",
                        "$gt0047='HP, PATIENT'",
                        "$gt0048='Four times per year'",
                        "$gt0050='307458005'",
                        "$gt0051='Have ACR measure four times a year or more, and before the control visit'"
                      ]
                    }
                  },
                  {
                    "type": "create",
                    "description": "{$gt0154.term}",
                    "resource_template": {
                      "template_id": "gt0035",
                      "assignments": [
                        "$gt0037=$currentDateTime+3,mo",
                        "$gt0036=$gt0249.term",
                        "$gt0063='HP, PATIENT'"
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "sv": {
        "id": "sv",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Kronisk njursjukdom riktlinjer för kontrollfrekvens för eGFR ",
            "description": "This guideline service deals with the determination of the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD.It implements the flowchart '5.4.7. Frequency of eGFR control' of deliverable D7.1 of the C3Cloud projet.This flowchart is based on the NICE CKD guideline CG182, Chapter 1.3, Table 2 [60, p. 26]. It represents the frequency of monitoring of GFR (number of times per year, by GFR and ACR category) for people with, or risk of, CKD.This CDSM accounts for reconciliation rules specified in deliverable D7.2 of the C3Cloud project."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "*(en) eGFRValue",
            "description": ""
          },
          "gt0004": {
            "id": "gt0004",
            "text": "*(en) eGFRObservation",
            "description": ""
          },
          "gt0005": {
            "id": "gt0005",
            "text": "*(en) eGFRcode",
            "description": ""
          },
          "gt0007": {
            "id": "gt0007",
            "text": "*(en) ACRValue",
            "description": ""
          },
          "gt0008": {
            "id": "gt0008",
            "text": "*(en) ACRObservation",
            "description": ""
          },
          "gt0009": {
            "id": "gt0009",
            "text": "*(en) ACRcode",
            "description": ""
          },
          "gt0010": {
            "id": "gt0010",
            "text": "*(en) FHIR-STU3-ProcedureRequest.generic.v0",
            "description": ""
          },
          "gt0011": {
            "id": "gt0011",
            "text": "*(en) FHIR-STU3-Goal.generic.v0",
            "description": ""
          },
          "gt0012": {
            "id": "gt0012",
            "text": "*(en) R2.1-Less than or equal to 1, G1G2A1",
            "description": ""
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "*(en) critical",
            "description": "*(en) critical"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "*(en) warning",
            "description": "*(en) warning"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "*(en) info",
            "description": "*(en) info"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "labelValue"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Övervaka frekvensen av eGFR-kontroller för personer med, eller i riskzonen för, kronisk njursjukdom",
            "description": "descriptionValue"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "*(en) value",
            "description": "*(en) /target/dueDate"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "*(en) descriptionValue",
            "description": "*(en) descriptionValue"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "*(en) value",
            "description": "*(en) /startDate"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "*(en) value",
            "description": "*(en) /description/text"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "*(en) FHIR-STU3-ProcedureRequest.generic.v0",
            "description": ""
          },
          "gt0028": {
            "id": "gt0028",
            "text": "*(en) value",
            "description": "*(en) /code/coding[0]"
          },
          "gt0029": {
            "id": "gt0029",
            "text": "*(en) code",
            "description": "*(en) /code/coding[0]"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "*(en) value",
            "description": "*(en) /code/text"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "*(en) value",
            "description": "*(en) /performer/display"
          },
          "gt0032": {
            "id": "gt0032",
            "text": "*(en) value",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0033": {
            "id": "gt0033",
            "text": "*(en) code",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0034": {
            "id": "gt0034",
            "text": "*(en) terminology",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0035": {
            "id": "gt0035",
            "text": "*(en) FHIR-STU3-Appointment.generic.v0",
            "description": ""
          },
          "gt0036": {
            "id": "gt0036",
            "text": "*(en) value",
            "description": "*(en) /description"
          },
          "gt0037": {
            "id": "gt0037",
            "text": "*(en) value",
            "description": "*(en) /start"
          },
          "gt0038": {
            "id": "gt0038",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara en gång per år eller färre",
            "description": "labelValue"
          },
          "gt0039": {
            "id": "gt0039",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0040": {
            "id": "gt0040",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0041": {
            "id": "gt0041",
            "text": "*(en) terminology",
            "description": "*(en) /code/coding[0]"
          },
          "gt0042": {
            "id": "gt0042",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0043": {
            "id": "gt0043",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0044": {
            "id": "gt0044",
            "text": "*(en) value",
            "description": "*(en) /code/coding[0]"
          },
          "gt0045": {
            "id": "gt0045",
            "text": "*(en) terminology",
            "description": "*(en) /code/coding[0]"
          },
          "gt0046": {
            "id": "gt0046",
            "text": "*(en) FHIR-STU3-ProcedureRequest.generic.v0",
            "description": ""
          },
          "gt0047": {
            "id": "gt0047",
            "text": "*(en) value",
            "description": "*(en) /performer/display"
          },
          "gt0048": {
            "id": "gt0048",
            "text": "*(en) value",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0049": {
            "id": "gt0049",
            "text": "*(en) terminologyId",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0050": {
            "id": "gt0050",
            "text": "*(en) code",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0051": {
            "id": "gt0051",
            "text": "*(en) value",
            "description": "*(en) /occurrenceTiming/code/text"
          },
          "gt0052": {
            "id": "gt0052",
            "text": "*(en) value",
            "description": "*(en) /code/coding[0]"
          },
          "gt0053": {
            "id": "gt0053",
            "text": "*(en) code",
            "description": "*(en) /code/coding[0]"
          },
          "gt0054": {
            "id": "gt0054",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0055": {
            "id": "gt0055",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0056": {
            "id": "gt0056",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0057": {
            "id": "gt0057",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0058": {
            "id": "gt0058",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0059": {
            "id": "gt0059",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0060": {
            "id": "gt0060",
            "text": "*(en) value",
            "description": "*(en) /specialty[0]/text"
          },
          "gt0061": {
            "id": "gt0061",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0062": {
            "id": "gt0062",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0063": {
            "id": "gt0063",
            "text": "*(en) value",
            "description": "*(en) /specialty[0]/text"
          },
          "gt0064": {
            "id": "gt0064",
            "text": "*(en) R2.2-Equal to 1, G1G2A2",
            "description": ""
          },
          "gt0065": {
            "id": "gt0065",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0066": {
            "id": "gt0066",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0067": {
            "id": "gt0067",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara en gång per år",
            "description": "labelValue"
          },
          "gt0068": {
            "id": "gt0068",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0069": {
            "id": "gt0069",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0070": {
            "id": "gt0070",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0071": {
            "id": "gt0071",
            "text": "*(en) Copy of R2.2-Equal to 1, G1G2A2",
            "description": ""
          },
          "gt0072": {
            "id": "gt0072",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0073": {
            "id": "gt0073",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0074": {
            "id": "gt0074",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara en gånr per år",
            "description": "labelValue"
          },
          "gt0075": {
            "id": "gt0075",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0076": {
            "id": "gt0076",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0077": {
            "id": "gt0077",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0078": {
            "id": "gt0078",
            "text": "*(en) R2.3-More than or equal to 1, G1G2A3",
            "description": ""
          },
          "gt0079": {
            "id": "gt0079",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0080": {
            "id": "gt0080",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0081": {
            "id": "gt0081",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara minst en gång per år",
            "description": "labelValue"
          },
          "gt0082": {
            "id": "gt0082",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0083": {
            "id": "gt0083",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0084": {
            "id": "gt0084",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0085": {
            "id": "gt0085",
            "text": "*(en) R2.4-Equal to 1, not DM, G3aA1A2",
            "description": ""
          },
          "gt0086": {
            "id": "gt0086",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0087": {
            "id": "gt0087",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0088": {
            "id": "gt0088",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara en gång per år",
            "description": "labelValue"
          },
          "gt0089": {
            "id": "gt0089",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0090": {
            "id": "gt0090",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0091": {
            "id": "gt0091",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0092": {
            "id": "gt0092",
            "text": "*(en) R2.5-Equal to 2, not DM, G3aA3",
            "description": ""
          },
          "gt0093": {
            "id": "gt0093",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0094": {
            "id": "gt0094",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0095": {
            "id": "gt0095",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara två gånger per år",
            "description": "labelValue"
          },
          "gt0096": {
            "id": "gt0096",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0097": {
            "id": "gt0097",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0098": {
            "id": "gt0098",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0099": {
            "id": "gt0099",
            "text": "*(en) R2.6-Less than or equal to 2, not DM, G3bA1",
            "description": ""
          },
          "gt0100": {
            "id": "gt0100",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0101": {
            "id": "gt0101",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0102": {
            "id": "gt0102",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara två gånger per år eller färre",
            "description": "labelValue"
          },
          "gt0103": {
            "id": "gt0103",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0104": {
            "id": "gt0104",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0105": {
            "id": "gt0105",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0106": {
            "id": "gt0106",
            "text": "*(en) R2.7-Equal to 2, not DM, G3bA2",
            "description": ""
          },
          "gt0107": {
            "id": "gt0107",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0108": {
            "id": "gt0108",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0109": {
            "id": "gt0109",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara två gånger per år",
            "description": "labelValue"
          },
          "gt0110": {
            "id": "gt0110",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0111": {
            "id": "gt0111",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0112": {
            "id": "gt0112",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0113": {
            "id": "gt0113",
            "text": "*(en) R2.8-More than or equal to 2, not DM, G3bA3",
            "description": ""
          },
          "gt0114": {
            "id": "gt0114",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0115": {
            "id": "gt0115",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0116": {
            "id": "gt0116",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara minst två gånger per år",
            "description": "labelValue"
          },
          "gt0117": {
            "id": "gt0117",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0118": {
            "id": "gt0118",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0119": {
            "id": "gt0119",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0120": {
            "id": "gt0120",
            "text": "*(en) R2.9-Equal to 2, G4A1A2",
            "description": ""
          },
          "gt0121": {
            "id": "gt0121",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0122": {
            "id": "gt0122",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0123": {
            "id": "gt0123",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara två gånger per år",
            "description": "labelValue"
          },
          "gt0124": {
            "id": "gt0124",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0125": {
            "id": "gt0125",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0126": {
            "id": "gt0126",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0127": {
            "id": "gt0127",
            "text": "*(en) R2.10-Equal to 3, G4A3",
            "description": ""
          },
          "gt0128": {
            "id": "gt0128",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0129": {
            "id": "gt0129",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0130": {
            "id": "gt0130",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara tre gånger per år",
            "description": "labelValue"
          },
          "gt0131": {
            "id": "gt0131",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0132": {
            "id": "gt0132",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0133": {
            "id": "gt0133",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0134": {
            "id": "gt0134",
            "text": "*(en) Copy of Copy of R2.9-Equal to 2, G4A1A2",
            "description": ""
          },
          "gt0135": {
            "id": "gt0135",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0136": {
            "id": "gt0136",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0137": {
            "id": "gt0137",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara två gånger per år",
            "description": "labelValue"
          },
          "gt0138": {
            "id": "gt0138",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0139": {
            "id": "gt0139",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0140": {
            "id": "gt0140",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0141": {
            "id": "gt0141",
            "text": "*(en) R2.11-Equal to 4, G5A1",
            "description": ""
          },
          "gt0142": {
            "id": "gt0142",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0143": {
            "id": "gt0143",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0144": {
            "id": "gt0144",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara fyra gånger per år",
            "description": "labelValue"
          },
          "gt0145": {
            "id": "gt0145",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0146": {
            "id": "gt0146",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0147": {
            "id": "gt0147",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0148": {
            "id": "gt0148",
            "text": "*(en) R2.12-More than or equal to 4, G5A2A3",
            "description": ""
          },
          "gt0149": {
            "id": "gt0149",
            "text": "Årlig frekvens för kontroll av eGFR",
            "description": "summaryValue"
          },
          "gt0150": {
            "id": "gt0150",
            "text": "Kom överens med patienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och kreatinin). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontrollfrekvensen för eGFR varierar beroende på patientens risk men anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul>",
            "description": "detailValue"
          },
          "gt0151": {
            "id": "gt0151",
            "text": "Frekvensen av eGFR-kontroller för personer med, eller med risk för, kronisk njursjukdom bör vara minst fyra gånger per år",
            "description": "labelValue"
          },
          "gt0152": {
            "id": "gt0152",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0153": {
            "id": "gt0153",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0154": {
            "id": "gt0154",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0156": {
            "id": "gt0156",
            "text": "*(en) Diabetes",
            "description": ""
          },
          "gt0157": {
            "id": "gt0157",
            "text": "*(en) Diabetescode",
            "description": ""
          },
          "gt0158": {
            "id": "gt0158",
            "text": "*(en) R2.4-5.DM-RF7-11, DM, G3a",
            "description": ""
          },
          "gt0159": {
            "id": "gt0159",
            "text": "Årlig frekvens för kontroll av eGFR och HbA1c",
            "description": "summaryValue"
          },
          "gt0160": {
            "id": "gt0160",
            "text": "Kom överens med diabetespatienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och HbA1c). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontroll av eGFR och HbA1C bör normalt ske 2 gånger per år med anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul> Planera uppföljningsbesök: 1/år hos läkare och 2/år hos sjuksköterska.",
            "description": "detailValue"
          },
          "gt0161": {
            "id": "gt0161",
            "text": "Frekvensen av eGFR-kontroller för personer med diabetes med, eller i riskzonen för, kronisk njursjukdom bör vara 3/år, 1/år hos läkare och 2/år hos sjuksköterska.",
            "description": "labelValue"
          },
          "gt0162": {
            "id": "gt0162",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0163": {
            "id": "gt0163",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0164": {
            "id": "gt0164",
            "text": "Kronisk njursjukdom kontrollbesök",
            "description": "descriptionValue"
          },
          "gt0165": {
            "id": "gt0165",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0166": {
            "id": "gt0166",
            "text": "Mät HbA1c",
            "description": "descriptionValue"
          },
          "gt0167": {
            "id": "gt0167",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0168": {
            "id": "gt0168",
            "text": "Kronisk njursjukdom kontrollbesök hos läkare",
            "description": "descriptionValue"
          },
          "gt0169": {
            "id": "gt0169",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0170": {
            "id": "gt0170",
            "text": "Kronisk njursjukdom kontrollbesök hos sjuksköterska",
            "description": "descriptionValue"
          },
          "gt0171": {
            "id": "gt0171",
            "text": "*(en) R2.6-8.DM-RF8-12, DM, G3b",
            "description": ""
          },
          "gt0172": {
            "id": "gt0172",
            "text": "Årlig frekvens för kontroll av eGFR och HbA1c",
            "description": "summaryValue"
          },
          "gt0173": {
            "id": "gt0173",
            "text": "Kom överens med diabetespatienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och HbA1c). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontroll av eGFR och HbA1C bör normalt ske 4 gånger per år med anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul> Planera uppföljningsbesök: 2/år hos läkare och 3/år hos sjuksköterska.",
            "description": "detailValue"
          },
          "gt0174": {
            "id": "gt0174",
            "text": "Frekvensen av eGFR-kontroller för personer med diabetes med, eller i riskzonen för, kronisk njursjukdom bör vara 5/år, 2/år hos läkare och 3/år hos sjuksköterska.",
            "description": "labelValue"
          },
          "gt0175": {
            "id": "gt0175",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0176": {
            "id": "gt0176",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0177": {
            "id": "gt0177",
            "text": "Mät HbA1c",
            "description": "descriptionValue"
          },
          "gt0178": {
            "id": "gt0178",
            "text": "Kronisk njursjukdom kontrollbesök hos läkare",
            "description": "descriptionValue"
          },
          "gt0179": {
            "id": "gt0179",
            "text": "Kronisk njursjukdom kontrollbesök hos sjuksköterska",
            "description": "descriptionValue"
          },
          "gt0180": {
            "id": "gt0180",
            "text": "*(en) Copy of R2.4-5.DM-RF7-11, DM, G3a",
            "description": ""
          },
          "gt0181": {
            "id": "gt0181",
            "text": "Årlig frekvens för kontroll av eGFR och HbA1c",
            "description": "summaryValue"
          },
          "gt0182": {
            "id": "gt0182",
            "text": "Kom överens med diabetespatienten med kronisk njursjukdom, eller risk för detta, om hur ofta kontroller skall ske (eGFR, albumin/kreatininkvot och HbA1c). Kom ihåg att kronisk njursjukdom inte är progressiv hos många människor. Kontroll av eGFR och HbA1C bör normalt ske 2 gånger per år med anpassning till individen enligt följande:<ul><li>den underliggande orsaken till kronisk njursjukdom </li><li> tidigare eGFR och albumin/kreatininkvot (men tänk på att ev. sjukdomsprogression ofta är icke-linjär) </li><li> andra sjukdomar, i synnerhet hjärtsvikt </li><li> förändrad behandling (renin-angiotensinsystem (RAS)-blockad, NSAID och diuretika) </li><li> interkurrenta sjukdomar.</li></ul> Planera uppföljningsbesök: 1/år hos läkare och 2/år hos sjuksköterska.",
            "description": "detailValue"
          },
          "gt0183": {
            "id": "gt0183",
            "text": "Frekvensen av eGFR-kontroller för personer med diabetes med, eller i riskzonen för, kronisk njursjukdom bör vara 3/år, 1/år hos läkare och 2/år hos sjuksköterska.",
            "description": "labelValue"
          },
          "gt0184": {
            "id": "gt0184",
            "text": "Mät eGFR ",
            "description": "descriptionValue"
          },
          "gt0185": {
            "id": "gt0185",
            "text": "Mät albumin/kreatininkvot",
            "description": "descriptionValue"
          },
          "gt0186": {
            "id": "gt0186",
            "text": "Mät HbA1c",
            "description": "descriptionValue"
          },
          "gt0187": {
            "id": "gt0187",
            "text": "Kronisk njursjukdom kontrollbesök hos läkare",
            "description": "descriptionValue"
          },
          "gt0188": {
            "id": "gt0188",
            "text": "Kronisk njursjukdom kontrollbesök hos sjuksköterska",
            "description": "descriptionValue"
          },
          "gt0190": {
            "id": "gt0190",
            "text": "*(en) Fuck",
            "description": "*(en) summaryValue"
          },
          "gt0191": {
            "id": "gt0191",
            "text": "*(en) bla bla",
            "description": "*(en) detailValue"
          },
          "gt0192": {
            "id": "gt0192",
            "text": "*(en) critical",
            "description": "*(en) critical"
          },
          "gt0193": {
            "id": "gt0193",
            "text": "*(en) warning",
            "description": "*(en) warning"
          },
          "gt0194": {
            "id": "gt0194",
            "text": "*(en) info",
            "description": "*(en) info"
          },
          "gt0195": {
            "id": "gt0195",
            "text": "*(en) labelValue",
            "description": "*(en) labelValue"
          },
          "gt0196": {
            "id": "gt0196",
            "text": "*(en) 1",
            "description": "*(en) labelValue"
          },
          "gt0197": {
            "id": "gt0197",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0198": {
            "id": "gt0198",
            "text": "*(en) Test",
            "description": "*(en) descriptionValue"
          },
          "gt0200": {
            "id": "gt0200",
            "text": "*(en) CKD",
            "description": ""
          },
          "gt0201": {
            "id": "gt0201",
            "text": "*(en) CKDcode",
            "description": ""
          },
          "gt0202": {
            "id": "gt0202",
            "text": "*(en) effectiveDateTime",
            "description": ""
          },
          "gt0203": {
            "id": "gt0203",
            "text": "*(en) effectiveDateTime",
            "description": ""
          },
          "gt0204": {
            "id": "gt0204",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0205": {
            "id": "gt0205",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0206": {
            "id": "gt0206",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0207": {
            "id": "gt0207",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0208": {
            "id": "gt0208",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0209": {
            "id": "gt0209",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0210": {
            "id": "gt0210",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0211": {
            "id": "gt0211",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0212": {
            "id": "gt0212",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0213": {
            "id": "gt0213",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0214": {
            "id": "gt0214",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0215": {
            "id": "gt0215",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0216": {
            "id": "gt0216",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0217": {
            "id": "gt0217",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0218": {
            "id": "gt0218",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0219": {
            "id": "gt0219",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0220": {
            "id": "gt0220",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0221": {
            "id": "gt0221",
            "text": "HbA1c",
            "description": ""
          },
          "gt0222": {
            "id": "gt0222",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning hos distriktsläkare 1 ggr/år",
            "description": ""
          },
          "gt0223": {
            "id": "gt0223",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning hos sköterska 2 ggr/år",
            "description": ""
          },
          "gt0224": {
            "id": "gt0224",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0225": {
            "id": "gt0225",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0226": {
            "id": "gt0226",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0227": {
            "id": "gt0227",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0228": {
            "id": "gt0228",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0229": {
            "id": "gt0229",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0230": {
            "id": "gt0230",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0231": {
            "id": "gt0231",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0232": {
            "id": "gt0232",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0233": {
            "id": "gt0233",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0234": {
            "id": "gt0234",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0235": {
            "id": "gt0235",
            "text": "HbA1c",
            "description": ""
          },
          "gt0236": {
            "id": "gt0236",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning hos distriktsläkare 2 ggr/år",
            "description": ""
          },
          "gt0237": {
            "id": "gt0237",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning hos sköterska 3 ggr/år",
            "description": ""
          },
          "gt0238": {
            "id": "gt0238",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0239": {
            "id": "gt0239",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0240": {
            "id": "gt0240",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0241": {
            "id": "gt0241",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0242": {
            "id": "gt0242",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0243": {
            "id": "gt0243",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0244": {
            "id": "gt0244",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0245": {
            "id": "gt0245",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0246": {
            "id": "gt0246",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          },
          "gt0247": {
            "id": "gt0247",
            "text": "eGFR-prov",
            "description": ""
          },
          "gt0248": {
            "id": "gt0248",
            "text": "Albumin/kreatinin-kvot i urinen",
            "description": ""
          },
          "gt0249": {
            "id": "gt0249",
            "text": "Kronisk njursjukdom, eGFR och albumin/kreatinin-kvot - uppföljning",
            "description": ""
          }
        }
      },
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "CKD Guideline GFR Monitoring Frequency Service",
            "description": "This guideline service deals with the determination of the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD.It implements the flowchart '5.4.7. Frequency of eGFR control' of deliverable D7.1 of the C3Cloud projet.This flowchart is based on the NICE CKD guideline CG182, Chapter 1.3, Table 2 [60, p. 26]. It represents the frequency of monitoring of GFR (number of times per year, by GFR and ACR category) for people with, or risk of, CKD.This CDSM accounts for reconciliation rules specified in deliverable D7.2 of the C3Cloud project."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "eGFRValue",
            "description": ""
          },
          "gt0004": {
            "id": "gt0004",
            "text": "eGFRObservation",
            "description": ""
          },
          "gt0005": {
            "id": "gt0005",
            "text": "eGFRcode",
            "description": ""
          },
          "gt0007": {
            "id": "gt0007",
            "text": "ACRValue",
            "description": ""
          },
          "gt0008": {
            "id": "gt0008",
            "text": "ACRObservation",
            "description": ""
          },
          "gt0009": {
            "id": "gt0009",
            "text": "ACRcode",
            "description": ""
          },
          "gt0010": {
            "id": "gt0010",
            "text": "FHIR-STU3-ProcedureRequest.generic.v0"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "FHIR-STU3-Goal.generic.v0"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "R2.1-Less than or equal to 1, G1G2A1"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "critical",
            "description": "critical"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "warning",
            "description": "warning"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "info",
            "description": "info"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Frequency of eGRF control per year",
            "description": "labelValue"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "description",
            "description": "description"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Monitor the frequency of GFR control for people with, or at risk of, CKD",
            "description": "descriptionValue"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "value",
            "description": "/target/dueDate"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "description",
            "description": "description"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "descriptionValue",
            "description": "descriptionValue"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "value",
            "description": "/startDate"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "value",
            "description": "/description/text"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "FHIR-STU3-ProcedureRequest.generic.v0"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "value",
            "description": "/code/coding[0]"
          },
          "gt0029": {
            "id": "gt0029",
            "text": "code",
            "description": "/code/coding[0]"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "value",
            "description": "/code/text"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "value",
            "description": "/performer/display"
          },
          "gt0032": {
            "id": "gt0032",
            "text": "value",
            "description": "/occurrenceTiming/code/coding"
          },
          "gt0033": {
            "id": "gt0033",
            "text": "code",
            "description": "/occurrenceTiming/code/coding"
          },
          "gt0034": {
            "id": "gt0034",
            "text": "terminology",
            "description": "/occurrenceTiming/code/coding"
          },
          "gt0035": {
            "id": "gt0035",
            "text": "FHIR-STU3-Appointment.generic.v0"
          },
          "gt0036": {
            "id": "gt0036",
            "text": "value",
            "description": "/description"
          },
          "gt0037": {
            "id": "gt0037",
            "text": "value",
            "description": "/start"
          },
          "gt0038": {
            "id": "gt0038",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be less than or equal to one time per year",
            "description": "labelValue"
          },
          "gt0039": {
            "id": "gt0039",
            "text": "description",
            "description": "description"
          },
          "gt0040": {
            "id": "gt0040",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0041": {
            "id": "gt0041",
            "text": "terminology",
            "description": "/code/coding[0]"
          },
          "gt0042": {
            "id": "gt0042",
            "text": "description",
            "description": "description"
          },
          "gt0043": {
            "id": "gt0043",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0044": {
            "id": "gt0044",
            "text": "value",
            "description": "/code/coding[0]"
          },
          "gt0045": {
            "id": "gt0045",
            "text": "terminology",
            "description": "/code/coding[0]"
          },
          "gt0046": {
            "id": "gt0046",
            "text": "FHIR-STU3-ProcedureRequest.generic.v0"
          },
          "gt0047": {
            "id": "gt0047",
            "text": "value",
            "description": "/performer/display"
          },
          "gt0048": {
            "id": "gt0048",
            "text": "value",
            "description": "/occurrenceTiming/code/coding"
          },
          "gt0049": {
            "id": "gt0049",
            "text": "terminologyId",
            "description": "/occurrenceTiming/code/coding"
          },
          "gt0050": {
            "id": "gt0050",
            "text": "code",
            "description": "/occurrenceTiming/code/coding"
          },
          "gt0051": {
            "id": "gt0051",
            "text": "value",
            "description": "/occurrenceTiming/code/text"
          },
          "gt0052": {
            "id": "gt0052",
            "text": "value",
            "description": "/code/coding[0]"
          },
          "gt0053": {
            "id": "gt0053",
            "text": "code",
            "description": "/code/coding[0]"
          },
          "gt0054": {
            "id": "gt0054",
            "text": "description",
            "description": "description"
          },
          "gt0055": {
            "id": "gt0055",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0056": {
            "id": "gt0056",
            "text": "description",
            "description": "description"
          },
          "gt0057": {
            "id": "gt0057",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0058": {
            "id": "gt0058",
            "text": "description",
            "description": "description"
          },
          "gt0059": {
            "id": "gt0059",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0060": {
            "id": "gt0060",
            "text": "value",
            "description": "/specialty[0]/text"
          },
          "gt0061": {
            "id": "gt0061",
            "text": "description",
            "description": "description"
          },
          "gt0062": {
            "id": "gt0062",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0063": {
            "id": "gt0063",
            "text": "value",
            "description": "/specialty[0]/text"
          },
          "gt0064": {
            "id": "gt0064",
            "text": "R2.2-Equal to 1, G1G2A2"
          },
          "gt0065": {
            "id": "gt0065",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0066": {
            "id": "gt0066",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0067": {
            "id": "gt0067",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to one time per year",
            "description": "labelValue"
          },
          "gt0068": {
            "id": "gt0068",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0069": {
            "id": "gt0069",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0070": {
            "id": "gt0070",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0071": {
            "id": "gt0071",
            "text": "Copy of R2.2-Equal to 1, G1G2A2"
          },
          "gt0072": {
            "id": "gt0072",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0073": {
            "id": "gt0073",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0074": {
            "id": "gt0074",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to one time per year",
            "description": "labelValue"
          },
          "gt0075": {
            "id": "gt0075",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0076": {
            "id": "gt0076",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0077": {
            "id": "gt0077",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0078": {
            "id": "gt0078",
            "text": "R2.3-More than or equal to 1, G1G2A3"
          },
          "gt0079": {
            "id": "gt0079",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0080": {
            "id": "gt0080",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0081": {
            "id": "gt0081",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to or more than one time per year",
            "description": "labelValue"
          },
          "gt0082": {
            "id": "gt0082",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0083": {
            "id": "gt0083",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0084": {
            "id": "gt0084",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0085": {
            "id": "gt0085",
            "text": "R2.4-Equal to 1, not DM, G3aA1A2"
          },
          "gt0086": {
            "id": "gt0086",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0087": {
            "id": "gt0087",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0088": {
            "id": "gt0088",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to one time per year",
            "description": "labelValue"
          },
          "gt0089": {
            "id": "gt0089",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0090": {
            "id": "gt0090",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0091": {
            "id": "gt0091",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0092": {
            "id": "gt0092",
            "text": "R2.5-Equal to 2, not DM, G3aA3"
          },
          "gt0093": {
            "id": "gt0093",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0094": {
            "id": "gt0094",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0095": {
            "id": "gt0095",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to two times per year",
            "description": "labelValue"
          },
          "gt0096": {
            "id": "gt0096",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0097": {
            "id": "gt0097",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0098": {
            "id": "gt0098",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0099": {
            "id": "gt0099",
            "text": "R2.6-Less than or equal to 2, not DM, G3bA1"
          },
          "gt0100": {
            "id": "gt0100",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0101": {
            "id": "gt0101",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0102": {
            "id": "gt0102",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be less than or equal to two times per year",
            "description": "labelValue"
          },
          "gt0103": {
            "id": "gt0103",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0104": {
            "id": "gt0104",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0105": {
            "id": "gt0105",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0106": {
            "id": "gt0106",
            "text": "R2.7-Equal to 2, not DM, G3bA2"
          },
          "gt0107": {
            "id": "gt0107",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0108": {
            "id": "gt0108",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0109": {
            "id": "gt0109",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to two times per year",
            "description": "labelValue"
          },
          "gt0110": {
            "id": "gt0110",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0111": {
            "id": "gt0111",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0112": {
            "id": "gt0112",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0113": {
            "id": "gt0113",
            "text": "R2.8-More than or equal to 2, not DM, G3bA3"
          },
          "gt0114": {
            "id": "gt0114",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0115": {
            "id": "gt0115",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0116": {
            "id": "gt0116",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be more than or equal to two times per year",
            "description": "labelValue"
          },
          "gt0117": {
            "id": "gt0117",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0118": {
            "id": "gt0118",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0119": {
            "id": "gt0119",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0120": {
            "id": "gt0120",
            "text": "R2.9-Equal to 2, G4A1A2"
          },
          "gt0121": {
            "id": "gt0121",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0122": {
            "id": "gt0122",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0123": {
            "id": "gt0123",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to two times per year",
            "description": "labelValue"
          },
          "gt0124": {
            "id": "gt0124",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0125": {
            "id": "gt0125",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0126": {
            "id": "gt0126",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0127": {
            "id": "gt0127",
            "text": "R2.10-Equal to 3, G4A3"
          },
          "gt0128": {
            "id": "gt0128",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0129": {
            "id": "gt0129",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0130": {
            "id": "gt0130",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to three times per year",
            "description": "labelValue"
          },
          "gt0131": {
            "id": "gt0131",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0132": {
            "id": "gt0132",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0133": {
            "id": "gt0133",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0134": {
            "id": "gt0134",
            "text": "Copy of Copy of R2.9-Equal to 2, G4A1A2"
          },
          "gt0135": {
            "id": "gt0135",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0136": {
            "id": "gt0136",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0137": {
            "id": "gt0137",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to two times per year",
            "description": "labelValue"
          },
          "gt0138": {
            "id": "gt0138",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0139": {
            "id": "gt0139",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0140": {
            "id": "gt0140",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0141": {
            "id": "gt0141",
            "text": "R2.11-Equal to 4, G5A1"
          },
          "gt0142": {
            "id": "gt0142",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0143": {
            "id": "gt0143",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0144": {
            "id": "gt0144",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be equal to four times per year",
            "description": "labelValue"
          },
          "gt0145": {
            "id": "gt0145",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0146": {
            "id": "gt0146",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0147": {
            "id": "gt0147",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0148": {
            "id": "gt0148",
            "text": "R2.12-More than or equal to 4, G5A2A3"
          },
          "gt0149": {
            "id": "gt0149",
            "text": "Frequency of eGFR control per year",
            "description": "summaryValue"
          },
          "gt0150": {
            "id": "gt0150",
            "text": "Agree the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR monitoring for people with, or at risk of, CKD, may vary depending on risk, but tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness </li><li> whether they have chosen conservative management of CKD.</li></ul>",
            "description": "detailValue"
          },
          "gt0151": {
            "id": "gt0151",
            "text": "The frequency of GFR control for people with, or at risk of, CKD should be more than or equal to four times per year",
            "description": "labelValue"
          },
          "gt0152": {
            "id": "gt0152",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0153": {
            "id": "gt0153",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0154": {
            "id": "gt0154",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0156": {
            "id": "gt0156",
            "text": "Diabetes",
            "description": ""
          },
          "gt0157": {
            "id": "gt0157",
            "text": "Diabetescode",
            "description": ""
          },
          "gt0158": {
            "id": "gt0158",
            "text": "R2.4-5.DM-RF7-11, DM, G3a"
          },
          "gt0159": {
            "id": "gt0159",
            "text": "Frequency of eGFR and HbA1c control per year",
            "description": "summaryValue"
          },
          "gt0160": {
            "id": "gt0160",
            "text": "Agree the frequency of monitoring (eGFR, ACR, and HbA1c) with the diabetic person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR and HbA1C monitoring for diabetic people with, or at risk of, CKD, should be: 2 times per year. But tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness whether they have chosen conservative management of CKD.</li></ul> Program the follow-up appointments: 1 per year with a GP and 2 with a nurse.",
            "description": "detailValue"
          },
          "gt0161": {
            "id": "gt0161",
            "text": "The frequency of GFR control for diabetic people with, or at risk of, CKD should be equal to three times per year, 1 with a GP and 2 with a nurse.",
            "description": "labelValue"
          },
          "gt0162": {
            "id": "gt0162",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0163": {
            "id": "gt0163",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0164": {
            "id": "gt0164",
            "text": "CKD follow-up Appointment",
            "description": "descriptionValue"
          },
          "gt0165": {
            "id": "gt0165",
            "text": "description",
            "description": "description"
          },
          "gt0166": {
            "id": "gt0166",
            "text": "HbA1c measure",
            "description": "descriptionValue"
          },
          "gt0167": {
            "id": "gt0167",
            "text": "description",
            "description": "description"
          },
          "gt0168": {
            "id": "gt0168",
            "text": "CKD follow-up appointment with GP",
            "description": "descriptionValue"
          },
          "gt0169": {
            "id": "gt0169",
            "text": "description",
            "description": "description"
          },
          "gt0170": {
            "id": "gt0170",
            "text": "CKD follow-up appointment with nurse",
            "description": "descriptionValue"
          },
          "gt0171": {
            "id": "gt0171",
            "text": "R2.6-8.DM-RF8-12, DM, G3b"
          },
          "gt0172": {
            "id": "gt0172",
            "text": "Frequency of eGFR and HbA1c control per year",
            "description": "summaryValue"
          },
          "gt0173": {
            "id": "gt0173",
            "text": "Agree the frequency of monitoring (eGFR, ACR, and HbA1c) with the diabetic person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR and HbA1C monitoring for diabetic people with, or at risk of, CKD, should be: 4 times per year. But tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness whether they have chosen conservative management of CKD.</li></ul> Program the follow-up appointments: 2 per year with a GP and 3 with a nurse.",
            "description": "detailValue"
          },
          "gt0174": {
            "id": "gt0174",
            "text": "The frequency of GFR control for diabetic people with, or at risk of, CKD should be equal to five times per year, 2 with a GP and 3 with a nurse.",
            "description": "labelValue"
          },
          "gt0175": {
            "id": "gt0175",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0176": {
            "id": "gt0176",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0177": {
            "id": "gt0177",
            "text": "HbA1c measure",
            "description": "descriptionValue"
          },
          "gt0178": {
            "id": "gt0178",
            "text": "CKD follow-up appointment with GP",
            "description": "descriptionValue"
          },
          "gt0179": {
            "id": "gt0179",
            "text": "CKD follow-up appointment with nurse",
            "description": "descriptionValue"
          },
          "gt0180": {
            "id": "gt0180",
            "text": "Copy of R2.4-5.DM-RF7-11, DM, G3a"
          },
          "gt0181": {
            "id": "gt0181",
            "text": "Frequency of eGFR and HbA1c control per year",
            "description": "summaryValue"
          },
          "gt0182": {
            "id": "gt0182",
            "text": "Agree the frequency of monitoring (eGFR, ACR, and HbA1c) with the diabetic person with, or at risk of, CKD; bear in mind that CKD is not progressive in many people. The frequency of GFR and HbA1C monitoring for diabetic people with, or at risk of, CKD, should be: 2 times per year. But tailor it to the person according to:<ul><li>the underlying cause of CKD </li><li> past patterns of eGFR and ACR (but be aware that CKD progression is often non-linear) </li><li> comorbidities, especially heart failure </li><li> changes to their treatment (such as renin-angiotensin-aldosterone system [RAAS] antagonists, NSAIDs and diuretics) </li><li> intercurrent illness whether they have chosen conservative management of CKD.</li></ul> Program the follow-up appointments: 1 per year with a GP and 2 with a nurse.",
            "description": "detailValue"
          },
          "gt0183": {
            "id": "gt0183",
            "text": "The frequency of GFR control for diabetic people with, or at risk of, CKD should be equal to three times per year, 1 with a GP and 2 with a nurse.",
            "description": "labelValue"
          },
          "gt0184": {
            "id": "gt0184",
            "text": "eGFR measure",
            "description": "descriptionValue"
          },
          "gt0185": {
            "id": "gt0185",
            "text": "ACR measure",
            "description": "descriptionValue"
          },
          "gt0186": {
            "id": "gt0186",
            "text": "HbA1c measure",
            "description": "descriptionValue"
          },
          "gt0187": {
            "id": "gt0187",
            "text": "CKD follow-up appointment with GP",
            "description": "descriptionValue"
          },
          "gt0188": {
            "id": "gt0188",
            "text": "CKD follow-up appointment with nurse",
            "description": "descriptionValue"
          },
          "gt0190": {
            "id": "gt0190",
            "text": "Fuck",
            "description": "summaryValue"
          },
          "gt0191": {
            "id": "gt0191",
            "text": "bla bla",
            "description": "detailValue"
          },
          "gt0192": {
            "id": "gt0192",
            "text": "critical",
            "description": "critical"
          },
          "gt0193": {
            "id": "gt0193",
            "text": "warning",
            "description": "warning"
          },
          "gt0194": {
            "id": "gt0194",
            "text": "info",
            "description": "info"
          },
          "gt0195": {
            "id": "gt0195",
            "text": "labelValue",
            "description": "labelValue"
          },
          "gt0196": {
            "id": "gt0196",
            "text": "1",
            "description": "labelValue"
          },
          "gt0197": {
            "id": "gt0197",
            "text": "description",
            "description": "description"
          },
          "gt0198": {
            "id": "gt0198",
            "text": "Test",
            "description": "descriptionValue"
          },
          "gt0200": {
            "id": "gt0200",
            "text": "CKD",
            "description": ""
          },
          "gt0201": {
            "id": "gt0201",
            "text": "CKDcode",
            "description": ""
          },
          "gt0202": {
            "id": "gt0202",
            "text": "eGFReffectiveDateTime",
            "description": ""
          },
          "gt0203": {
            "id": "gt0203",
            "text": "ACReffectiveDateTime",
            "description": ""
          },
          "gt0204": {
            "id": "gt0204",
            "text": "eGFR test",
            "description": ""
          },
          "gt0205": {
            "id": "gt0205",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0206": {
            "id": "gt0206",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0207": {
            "id": "gt0207",
            "text": "eGFR test",
            "description": ""
          },
          "gt0208": {
            "id": "gt0208",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0209": {
            "id": "gt0209",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0210": {
            "id": "gt0210",
            "text": "eGFR test",
            "description": ""
          },
          "gt0211": {
            "id": "gt0211",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0212": {
            "id": "gt0212",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0213": {
            "id": "gt0213",
            "text": "eGFR test",
            "description": ""
          },
          "gt0214": {
            "id": "gt0214",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0215": {
            "id": "gt0215",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0216": {
            "id": "gt0216",
            "text": "eGFR test",
            "description": ""
          },
          "gt0217": {
            "id": "gt0217",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0218": {
            "id": "gt0218",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0219": {
            "id": "gt0219",
            "text": "eGFR test",
            "description": ""
          },
          "gt0220": {
            "id": "gt0220",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0221": {
            "id": "gt0221",
            "text": "Hemoglobin A1c/Hemoglobin.total in Blood by HPLC",
            "description": ""
          },
          "gt0222": {
            "id": "gt0222",
            "text": "CKD eGFR and ACR Follow up appointment with GP once a year",
            "description": ""
          },
          "gt0223": {
            "id": "gt0223",
            "text": "CKD eGFR and ACR Follow up appointment with nurse twice a year",
            "description": ""
          },
          "gt0224": {
            "id": "gt0224",
            "text": "eGFR test",
            "description": ""
          },
          "gt0225": {
            "id": "gt0225",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0226": {
            "id": "gt0226",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0227": {
            "id": "gt0227",
            "text": "eGFR test",
            "description": ""
          },
          "gt0228": {
            "id": "gt0228",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0229": {
            "id": "gt0229",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0230": {
            "id": "gt0230",
            "text": "eGFR test",
            "description": ""
          },
          "gt0231": {
            "id": "gt0231",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0232": {
            "id": "gt0232",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0233": {
            "id": "gt0233",
            "text": "eGFR test",
            "description": ""
          },
          "gt0234": {
            "id": "gt0234",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0235": {
            "id": "gt0235",
            "text": "Hemoglobin A1c/Hemoglobin.total in Blood by HPLC",
            "description": ""
          },
          "gt0236": {
            "id": "gt0236",
            "text": "CKD eGFR and ACR Follow up appointment with GP twice a year",
            "description": ""
          },
          "gt0237": {
            "id": "gt0237",
            "text": "CKD eGFR and ACR Follow up appointment with nurse three times a year",
            "description": ""
          },
          "gt0238": {
            "id": "gt0238",
            "text": "eGFR test",
            "description": ""
          },
          "gt0239": {
            "id": "gt0239",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0240": {
            "id": "gt0240",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0241": {
            "id": "gt0241",
            "text": "eGFR test",
            "description": ""
          },
          "gt0242": {
            "id": "gt0242",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0243": {
            "id": "gt0243",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0244": {
            "id": "gt0244",
            "text": "eGFR test",
            "description": ""
          },
          "gt0245": {
            "id": "gt0245",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0246": {
            "id": "gt0246",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          },
          "gt0247": {
            "id": "gt0247",
            "text": "eGFR test",
            "description": ""
          },
          "gt0248": {
            "id": "gt0248",
            "text": "Albumin/Creatinine [Mass Ratio] in Urine",
            "description": ""
          },
          "gt0249": {
            "id": "gt0249",
            "text": "CKD eGFR and ACR Follow up Appointment",
            "description": ""
          }
        }
      },
      "es": {
        "id": "es",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Servicio de frecuencia de monitorización del filtrado glomerular de la  guía para Insuficiencia renal crónica ",
            "description": "This guideline service deals with the determination of the frequency of monitoring (eGFR, creatinine and ACR) with the person with, or at risk of, CKD.It implements the flowchart '5.4.7. Frequency of eGFR control' of deliverable D7.1 of the C3Cloud projet.This flowchart is based on the NICE CKD guideline CG182, Chapter 1.3, Table 2 [60, p. 26]. It represents the frequency of monitoring of GFR (number of times per year, by GFR and ACR category) for people with, or risk of, CKD.This CDSM accounts for reconciliation rules specified in deliverable D7.2 of the C3Cloud project."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "*(en) eGFRValue",
            "description": ""
          },
          "gt0004": {
            "id": "gt0004",
            "text": "*(en) eGFRObservation",
            "description": ""
          },
          "gt0005": {
            "id": "gt0005",
            "text": "*(en) eGFRcode",
            "description": ""
          },
          "gt0007": {
            "id": "gt0007",
            "text": "*(en) ACRValue",
            "description": ""
          },
          "gt0008": {
            "id": "gt0008",
            "text": "*(en) ACRObservation",
            "description": ""
          },
          "gt0009": {
            "id": "gt0009",
            "text": "*(en) ACRcode",
            "description": ""
          },
          "gt0010": {
            "id": "gt0010",
            "text": "*(en) FHIR-STU3-ProcedureRequest.generic.v0",
            "description": ""
          },
          "gt0011": {
            "id": "gt0011",
            "text": "*(en) FHIR-STU3-Goal.generic.v0",
            "description": ""
          },
          "gt0012": {
            "id": "gt0012",
            "text": "*(en) R2.1-Less than or equal to 1, G1G2A1",
            "description": ""
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "*(en) critical",
            "description": "*(en) critical"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "*(en) warning",
            "description": "*(en) warning"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "*(en) info",
            "description": "*(en) info"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "labelValue"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Monitorice la frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica ",
            "description": "descriptionValue"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "*(en) value",
            "description": "*(en) /target/dueDate"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "*(en) descriptionValue",
            "description": "*(en) descriptionValue"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "*(en) value",
            "description": "*(en) /startDate"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "*(en) value",
            "description": "*(en) /description/text"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "*(en) FHIR-STU3-ProcedureRequest.generic.v0",
            "description": ""
          },
          "gt0028": {
            "id": "gt0028",
            "text": "*(en) value",
            "description": "*(en) /code/coding[0]"
          },
          "gt0029": {
            "id": "gt0029",
            "text": "*(en) code",
            "description": "*(en) /code/coding[0]"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "*(en) value",
            "description": "*(en) /code/text"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "*(en) value",
            "description": "*(en) /performer/display"
          },
          "gt0032": {
            "id": "gt0032",
            "text": "*(en) value",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0033": {
            "id": "gt0033",
            "text": "*(en) code",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0034": {
            "id": "gt0034",
            "text": "*(en) terminology",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0035": {
            "id": "gt0035",
            "text": "*(en) FHIR-STU3-Appointment.generic.v0",
            "description": ""
          },
          "gt0036": {
            "id": "gt0036",
            "text": "*(en) value",
            "description": "*(en) /description"
          },
          "gt0037": {
            "id": "gt0037",
            "text": "*(en) value",
            "description": "*(en) /start"
          },
          "gt0038": {
            "id": "gt0038",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica,  debe ser menor o igual a una vez al año",
            "description": "labelValue"
          },
          "gt0039": {
            "id": "gt0039",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0040": {
            "id": "gt0040",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0041": {
            "id": "gt0041",
            "text": "*(en) terminology",
            "description": "*(en) /code/coding[0]"
          },
          "gt0042": {
            "id": "gt0042",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0043": {
            "id": "gt0043",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0044": {
            "id": "gt0044",
            "text": "*(en) value",
            "description": "*(en) /code/coding[0]"
          },
          "gt0045": {
            "id": "gt0045",
            "text": "*(en) terminology",
            "description": "*(en) /code/coding[0]"
          },
          "gt0046": {
            "id": "gt0046",
            "text": "*(en) FHIR-STU3-ProcedureRequest.generic.v0",
            "description": ""
          },
          "gt0047": {
            "id": "gt0047",
            "text": "*(en) value",
            "description": "*(en) /performer/display"
          },
          "gt0048": {
            "id": "gt0048",
            "text": "*(en) value",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0049": {
            "id": "gt0049",
            "text": "*(en) terminologyId",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0050": {
            "id": "gt0050",
            "text": "*(en) code",
            "description": "*(en) /occurrenceTiming/code/coding"
          },
          "gt0051": {
            "id": "gt0051",
            "text": "*(en) value",
            "description": "*(en) /occurrenceTiming/code/text"
          },
          "gt0052": {
            "id": "gt0052",
            "text": "*(en) value",
            "description": "*(en) /code/coding[0]"
          },
          "gt0053": {
            "id": "gt0053",
            "text": "*(en) code",
            "description": "*(en) /code/coding[0]"
          },
          "gt0054": {
            "id": "gt0054",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0055": {
            "id": "gt0055",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0056": {
            "id": "gt0056",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0057": {
            "id": "gt0057",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0058": {
            "id": "gt0058",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0059": {
            "id": "gt0059",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0060": {
            "id": "gt0060",
            "text": "*(en) value",
            "description": "*(en) /specialty[0]/text"
          },
          "gt0061": {
            "id": "gt0061",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0062": {
            "id": "gt0062",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0063": {
            "id": "gt0063",
            "text": "*(en) value",
            "description": "*(en) /specialty[0]/text"
          },
          "gt0064": {
            "id": "gt0064",
            "text": "*(en) R2.2-Equal to 1, G1G2A2",
            "description": ""
          },
          "gt0065": {
            "id": "gt0065",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0066": {
            "id": "gt0066",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0067": {
            "id": "gt0067",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica, debe ser una vez por año",
            "description": "labelValue"
          },
          "gt0068": {
            "id": "gt0068",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0069": {
            "id": "gt0069",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0070": {
            "id": "gt0070",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0071": {
            "id": "gt0071",
            "text": "*(en) Copy of R2.2-Equal to 1, G1G2A2",
            "description": ""
          },
          "gt0072": {
            "id": "gt0072",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0073": {
            "id": "gt0073",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0074": {
            "id": "gt0074",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica, debe ser una vez por año",
            "description": "labelValue"
          },
          "gt0075": {
            "id": "gt0075",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0076": {
            "id": "gt0076",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0077": {
            "id": "gt0077",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0078": {
            "id": "gt0078",
            "text": "*(en) R2.3-More than or equal to 1, G1G2A3",
            "description": ""
          },
          "gt0079": {
            "id": "gt0079",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0080": {
            "id": "gt0080",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0081": {
            "id": "gt0081",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica,  debe ser una o más vez al año",
            "description": "labelValue"
          },
          "gt0082": {
            "id": "gt0082",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0083": {
            "id": "gt0083",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0084": {
            "id": "gt0084",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0085": {
            "id": "gt0085",
            "text": "*(en) R2.4-Equal to 1, not DM, G3aA1A2",
            "description": ""
          },
          "gt0086": {
            "id": "gt0086",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0087": {
            "id": "gt0087",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0088": {
            "id": "gt0088",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica, debe ser una vez por año",
            "description": "labelValue"
          },
          "gt0089": {
            "id": "gt0089",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0090": {
            "id": "gt0090",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0091": {
            "id": "gt0091",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0092": {
            "id": "gt0092",
            "text": "*(en) R2.5-Equal to 2, not DM, G3aA3",
            "description": ""
          },
          "gt0093": {
            "id": "gt0093",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0094": {
            "id": "gt0094",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0095": {
            "id": "gt0095",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica,  debe ser dos veces por año",
            "description": "labelValue"
          },
          "gt0096": {
            "id": "gt0096",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0097": {
            "id": "gt0097",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0098": {
            "id": "gt0098",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0099": {
            "id": "gt0099",
            "text": "*(en) R2.6-Less than or equal to 2, not DM, G3bA1",
            "description": ""
          },
          "gt0100": {
            "id": "gt0100",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0101": {
            "id": "gt0101",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0102": {
            "id": "gt0102",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica, debe ser menor o igual a dos veces por año",
            "description": "labelValue"
          },
          "gt0103": {
            "id": "gt0103",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0104": {
            "id": "gt0104",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0105": {
            "id": "gt0105",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0106": {
            "id": "gt0106",
            "text": "*(en) R2.7-Equal to 2, not DM, G3bA2",
            "description": ""
          },
          "gt0107": {
            "id": "gt0107",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0108": {
            "id": "gt0108",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0109": {
            "id": "gt0109",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica,  debe ser dos veces por año",
            "description": "labelValue"
          },
          "gt0110": {
            "id": "gt0110",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0111": {
            "id": "gt0111",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0112": {
            "id": "gt0112",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0113": {
            "id": "gt0113",
            "text": "*(en) R2.8-More than or equal to 2, not DM, G3bA3",
            "description": ""
          },
          "gt0114": {
            "id": "gt0114",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0115": {
            "id": "gt0115",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0116": {
            "id": "gt0116",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica, debe ser mayor o igual a dos veces por año",
            "description": "labelValue"
          },
          "gt0117": {
            "id": "gt0117",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0118": {
            "id": "gt0118",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0119": {
            "id": "gt0119",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0120": {
            "id": "gt0120",
            "text": "*(en) R2.9-Equal to 2, G4A1A2",
            "description": ""
          },
          "gt0121": {
            "id": "gt0121",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0122": {
            "id": "gt0122",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0123": {
            "id": "gt0123",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica,  debe ser dos veces por año",
            "description": "labelValue"
          },
          "gt0124": {
            "id": "gt0124",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0125": {
            "id": "gt0125",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0126": {
            "id": "gt0126",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0127": {
            "id": "gt0127",
            "text": "*(en) R2.10-Equal to 3, G4A3",
            "description": ""
          },
          "gt0128": {
            "id": "gt0128",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0129": {
            "id": "gt0129",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0130": {
            "id": "gt0130",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica, debe ser  tres veces al año",
            "description": "labelValue"
          },
          "gt0131": {
            "id": "gt0131",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0132": {
            "id": "gt0132",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0133": {
            "id": "gt0133",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0134": {
            "id": "gt0134",
            "text": "*(en) Copy of Copy of R2.9-Equal to 2, G4A1A2",
            "description": ""
          },
          "gt0135": {
            "id": "gt0135",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0136": {
            "id": "gt0136",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0137": {
            "id": "gt0137",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica,  debe ser dos veces por año",
            "description": "labelValue"
          },
          "gt0138": {
            "id": "gt0138",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0139": {
            "id": "gt0139",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0140": {
            "id": "gt0140",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0141": {
            "id": "gt0141",
            "text": "*(en) R2.11-Equal to 4, G5A1",
            "description": ""
          },
          "gt0142": {
            "id": "gt0142",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0143": {
            "id": "gt0143",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0144": {
            "id": "gt0144",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica debe ser  cuatro veces al año",
            "description": "labelValue"
          },
          "gt0145": {
            "id": "gt0145",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0146": {
            "id": "gt0146",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0147": {
            "id": "gt0147",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0148": {
            "id": "gt0148",
            "text": "*(en) R2.12-More than or equal to 4, G5A2A3",
            "description": ""
          },
          "gt0149": {
            "id": "gt0149",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular",
            "description": "summaryValue"
          },
          "gt0150": {
            "id": "gt0150",
            "text": "Acuerde la frecuencia de monitorización de los parámetros tasa de filtrado glomerular, creatinina y cociente albúmina/creatinina en orina con la persona que tiene o está en riesgo de tener Insuficiencia Renal Crónica; tenga en cuenta que la Insuficiencia Renal Crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular para las personas con, o en riesgo de Insuficiencia Renal Crónica, puede variar dependiendo del riesgo, pero adéptela a la persona de acuerdo con:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa de filtrado glomerular  y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica a menudo no es lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente </li><li>si han optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul>",
            "description": "detailValue"
          },
          "gt0151": {
            "id": "gt0151",
            "text": "La frecuencia de control del filtrado glomerular para las personas con o en riesgo de Insuficiencia Renal Crónica, debe ser mayor o igual a cuatro veces al año",
            "description": "labelValue"
          },
          "gt0152": {
            "id": "gt0152",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0153": {
            "id": "gt0153",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0154": {
            "id": "gt0154",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0156": {
            "id": "gt0156",
            "text": "*(en) Diabetes",
            "description": ""
          },
          "gt0157": {
            "id": "gt0157",
            "text": "*(en) Diabetescode",
            "description": ""
          },
          "gt0158": {
            "id": "gt0158",
            "text": "*(en) R2.4-5.DM-RF7-11, DM, G3a",
            "description": ""
          },
          "gt0159": {
            "id": "gt0159",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular y de la HbA1c",
            "description": "summaryValue"
          },
          "gt0160": {
            "id": "gt0160",
            "text": "    Acuerde la frecuencia de monitorización de los parámetros (tasa estimada de filtrado glomerular, cociente albúmina/creatinina en orina y HbA1c) con el paciente diabético que padece o corre el riesgo de padecer Insuficiencia renal crónica; tener en cuenta que la Insuficiencia renal crónica no es progresiva en muchas personas. La frecuencia de la monitorización del filtrado glomerular y  HbA1C para las personas diabéticas con, o en riesgo de Insuficiencia renal crónica, debe ser  2 veces al año. Pero debe adaptarse a cada paciente de acuerdo a:<ul><li>  la causa subyacente de la Insuficiencia Renal Crónica </li><li>patrones anteriores de tasa estimada de filtrado glomerular y cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia Renal Crónica es a menudo no lineal) </li><li>comorbilidades, especialmente la insuficiencia cardíaca </li><li>cambios en su tratamiento (como los antagonistas del sistema renina-angiotensina-aldosterona[RASA], los Medicamentos antiinflamatorios no esteroideos y los diuréticos) </li><li>enfermedad intercurrente, independientemente de que se haya optado por un tratamiento conservador de la Insuficiencia Renal Crónica.</li></ul> Programe las citas de seguimiento: 1 al año con un médico de familia y 2 con una enfermera.",
            "description": "detailValue"
          },
          "gt0161": {
            "id": "gt0161",
            "text": "La frecuencia de control del filtrado glomerular para las personas con diabetes o en riesgo de Insuficiencia Renal Crónica, debe ser igual a tres veces por año, 1 con el médico de familia y 2 con una enfermera.",
            "description": "labelValue"
          },
          "gt0162": {
            "id": "gt0162",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0163": {
            "id": "gt0163",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0164": {
            "id": "gt0164",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica",
            "description": "descriptionValue"
          },
          "gt0165": {
            "id": "gt0165",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0166": {
            "id": "gt0166",
            "text": "Medida de HbA1c",
            "description": "descriptionValue"
          },
          "gt0167": {
            "id": "gt0167",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0168": {
            "id": "gt0168",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica con el médico de familia",
            "description": "descriptionValue"
          },
          "gt0169": {
            "id": "gt0169",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0170": {
            "id": "gt0170",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica con la enfermera",
            "description": "descriptionValue"
          },
          "gt0171": {
            "id": "gt0171",
            "text": "*(en) R2.6-8.DM-RF8-12, DM, G3b",
            "description": ""
          },
          "gt0172": {
            "id": "gt0172",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular y de la HbA1c",
            "description": "summaryValue"
          },
          "gt0173": {
            "id": "gt0173",
            "text": " Acuerde la frecuencia de monitorización de los parámetros (tasa estimada de filtrado glomeruar, cociente albúmina/creatinina en orina y HbA1c) con el paciente diabético con, o en riesgo de, padecer Insuficiencia renal crónica; tenga en cuenta que la Insuficiencia renal crónica no es progresiva en muchas personas. La frecuencia de la TFG y el seguimiento de HbA1C para las personas con diabetes o en riesgo de Insuficiencia renal crónica, debe ser: 4 veces al año. Pero a medida que la persona en función de:<ul><li>la causa subyacente de la Insuficiencia renal crónica </li><li> pasado patrones del EGFR y ACR (pero tenga en cuenta que la progresión de la ERC es a menudo no lineal) </li><li> comorbilidades, especialmente insuficiencia cardiaca </li><li> cambios en su tratamiento (como la renina -angiotensina-aldosterona [RASA] antagonistas, Medicamentos antiinflamatorios no esteroideos y diuréticos) </li><li> enfermedades intercurrentes si han elegido el tratamiento conservador de la ERC.</li></ul> Programar las citas de seguimiento: 2 por año con un médico de cabecera y 3 con una enfermera.",
            "description": "detailValue"
          },
          "gt0174": {
            "id": "gt0174",
            "text": "La frecuencia de control del filtrado glomerular para las personas con diabetes o en riesgo de Insuficiencia Renal Crónica debe ser cinco veces al año: 2 con el médico de familia y 3 con una enfermera.",
            "description": "labelValue"
          },
          "gt0175": {
            "id": "gt0175",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0176": {
            "id": "gt0176",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0177": {
            "id": "gt0177",
            "text": "medida de HbA1c",
            "description": "descriptionValue"
          },
          "gt0178": {
            "id": "gt0178",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica con el médico de familia",
            "description": "descriptionValue"
          },
          "gt0179": {
            "id": "gt0179",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica con la enfermera",
            "description": "descriptionValue"
          },
          "gt0180": {
            "id": "gt0180",
            "text": "*(en) Copy of R2.4-5.DM-RF7-11, DM, G3a",
            "description": ""
          },
          "gt0181": {
            "id": "gt0181",
            "text": "Frecuencia anual del control de la tasa de filtrado glomerular y de la HbA1c",
            "description": "summaryValue"
          },
          "gt0182": {
            "id": "gt0182",
            "text": "Acuerde  la frecuencia de monitorización de los parámetros (filtrado glomerular, cociente albúmina/creatinina en orina y HbA1c) conel paciente diabético con, o en riesgo de, Insuficiencia renal crónica; tenga en cuenta que Insuficiencia renal crónica no es progresiva en muchas personas. La frecuencia del filtrado glomerular y el seguimiento de HbA1C para las personas con diabetes o en riesgo de Insuficiencia renal crónica, debe ser  2 veces por año. Pero adáptela a la persona en función de:<ul><li>la causa subyacente de la insuficiencia renal crónica </li><li>  patrones previos de la tasa de filtrado glomerular y el cociente albúmina/creatinina en orina (pero tenga en cuenta que la progresión de la Insuficiencia renal crónica no es a menudo lineal) </li><li> comorbilidades, especialmente insuficiencia cardiaca </li><li> cambios en su tratamiento (como los antagonistas del sistema la renina -angiotensina-aldosterona [RASA], Medicamentos antiinflamatorios no esteroideos y diuréticos) </li><li> enfermedades intercurrentes si han elegido el tratamiento conservador de la Insuficiencia renal crónica.</li></ul> Programar las citas de seguimiento: 1 por año con un médico de familia y 2 con una enfermera.",
            "description": "detailValue"
          },
          "gt0183": {
            "id": "gt0183",
            "text": "La frecuencia de control del filtrado glomerular para las personas con diabetes o en riesgo de Insuficiencia Renal Crónica, debe ser igual a tres veces por año, 1 con el médico de familia y 2 con una enfermera.",
            "description": "labelValue"
          },
          "gt0184": {
            "id": "gt0184",
            "text": "Medida del filtrado glomerular",
            "description": "descriptionValue"
          },
          "gt0185": {
            "id": "gt0185",
            "text": "Medida del Cociente albúmina/creatinina en orina",
            "description": "descriptionValue"
          },
          "gt0186": {
            "id": "gt0186",
            "text": "medida de HbA1c",
            "description": "descriptionValue"
          },
          "gt0187": {
            "id": "gt0187",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica con el médico de familia",
            "description": "descriptionValue"
          },
          "gt0188": {
            "id": "gt0188",
            "text": "Cita de seguimiento de Insuficiencia Renal Crónica con la enfermera",
            "description": "descriptionValue"
          },
          "gt0190": {
            "id": "gt0190",
            "text": "*(en) Fuck",
            "description": "*(en) summaryValue"
          },
          "gt0191": {
            "id": "gt0191",
            "text": "*(en) bla bla",
            "description": "*(en) detailValue"
          },
          "gt0192": {
            "id": "gt0192",
            "text": "*(en) critical",
            "description": "*(en) critical"
          },
          "gt0193": {
            "id": "gt0193",
            "text": "*(en) warning",
            "description": "*(en) warning"
          },
          "gt0194": {
            "id": "gt0194",
            "text": "*(en) info",
            "description": "*(en) info"
          },
          "gt0195": {
            "id": "gt0195",
            "text": "*(en) labelValue",
            "description": "*(en) labelValue"
          },
          "gt0196": {
            "id": "gt0196",
            "text": "*(en) 1",
            "description": "*(en) labelValue"
          },
          "gt0197": {
            "id": "gt0197",
            "text": "*(en) description",
            "description": "*(en) description"
          },
          "gt0198": {
            "id": "gt0198",
            "text": "*(en) Test",
            "description": "*(en) descriptionValue"
          },
          "gt0200": {
            "id": "gt0200",
            "text": "*(en) CKD",
            "description": ""
          },
          "gt0201": {
            "id": "gt0201",
            "text": "*(en) CKDcode",
            "description": ""
          },
          "gt0202": {
            "id": "gt0202",
            "text": "*(en) effectiveDateTime",
            "description": ""
          },
          "gt0203": {
            "id": "gt0203",
            "text": "*(en) effectiveDateTime",
            "description": ""
          },
          "gt0204": {
            "id": "gt0204",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0205": {
            "id": "gt0205",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0206": {
            "id": "gt0206",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0207": {
            "id": "gt0207",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0208": {
            "id": "gt0208",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0209": {
            "id": "gt0209",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0210": {
            "id": "gt0210",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0211": {
            "id": "gt0211",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0212": {
            "id": "gt0212",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0213": {
            "id": "gt0213",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0214": {
            "id": "gt0214",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0215": {
            "id": "gt0215",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0216": {
            "id": "gt0216",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0217": {
            "id": "gt0217",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0218": {
            "id": "gt0218",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0219": {
            "id": "gt0219",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0220": {
            "id": "gt0220",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0221": {
            "id": "gt0221",
            "text": "HbA1c/Hemoglobina total en sangre por HPLC",
            "description": ""
          },
          "gt0222": {
            "id": "gt0222",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica con el médico de Atención Primaria una vez al año",
            "description": ""
          },
          "gt0223": {
            "id": "gt0223",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica con la enfermera 2 veces al año (cada 6 meses)",
            "description": ""
          },
          "gt0224": {
            "id": "gt0224",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0225": {
            "id": "gt0225",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0226": {
            "id": "gt0226",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0227": {
            "id": "gt0227",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0228": {
            "id": "gt0228",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0229": {
            "id": "gt0229",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0230": {
            "id": "gt0230",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0231": {
            "id": "gt0231",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0232": {
            "id": "gt0232",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0233": {
            "id": "gt0233",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0234": {
            "id": "gt0234",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0235": {
            "id": "gt0235",
            "text": "HbA1c/Hemoglobina total en sangre por HPLC",
            "description": ""
          },
          "gt0236": {
            "id": "gt0236",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica con el médico de Atención Primaria  2 veces al año (cada 6 meses)",
            "description": ""
          },
          "gt0237": {
            "id": "gt0237",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica con la enfermera 3 veces al año (cada 4 meses)",
            "description": ""
          },
          "gt0238": {
            "id": "gt0238",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0239": {
            "id": "gt0239",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0240": {
            "id": "gt0240",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0241": {
            "id": "gt0241",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0242": {
            "id": "gt0242",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0243": {
            "id": "gt0243",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0244": {
            "id": "gt0244",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0245": {
            "id": "gt0245",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0246": {
            "id": "gt0246",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          },
          "gt0247": {
            "id": "gt0247",
            "text": "Análisis del filtrado glomerular",
            "description": ""
          },
          "gt0248": {
            "id": "gt0248",
            "text": "Cociente albúmina/creatinina en orina",
            "description": ""
          },
          "gt0249": {
            "id": "gt0249",
            "text": "Análisis del filtrado glomerular y del cociente albúmina/creatinina en orina y cita de seguimiento de Insuficiencia Renal Crónica",
            "description": ""
          }
        }
      }
    },
    "term_bindings": {
      "ICD-10-SE": {
        "id": "ICD-10-SE",
        "bindings": {
          "gt0201": {
            "codes": [
              "ICD-10-SE::N18",
              "ICD-10-SE::N19",
              "ICD-10-SE::I120",
              "ICD-10-SE::I131"
            ]
          },
          "gt0157": {
            "codes": [
              "ICD-10-SE::E10",
              "ICD-10-SE::E11",
              "ICD-10-SE::E12",
              "ICD-10-SE::E13",
              "ICD-10-SE::E14"
            ]
          }
        }
      },
      "NPU": {
        "id": "NPU",
        "bindings": {
          "gt0009": {
            "codes": [
              "NPU::XKREAINDX"
            ]
          },
          "gt0005": {
            "codes": [
              "NPU::EGFRKRE"
            ]
          }
        }
      },
      "DBP": {
        "id": "DBP",
        "bindings": {
          "gt0009": {
            "codes": [
              "DBP::907"
            ]
          },
          "gt0005": {
            "codes": [
              "DBP::33382"
            ]
          }
        }
      },
      "LOINC": {
        "id": "LOINC",
        "bindings": {
          "gt0009": {
            "codes": [
              "LOINC::32294-1"
            ]
          },
          "gt0005": {
            "codes": [
              "LOINC::33914-3"
            ]
          }
        }
      },
      "CIE-10-CM-ES": {
        "id": "CIE-10-CM-ES",
        "bindings": {
          "gt0201": {
            "codes": [
              "CIE-10-CM-ES::N18",
              "CIE-10-CM-ES::N19",
              "CIE-10-CM-ES::I12.0",
              "CIE-10-CM-ES::I13.1"
            ]
          },
          "gt0157": {
            "codes": [
              "CIE-10-CM-ES::E10",
              "CIE-10-CM-ES::E11",
              "CIE-10-CM-ES::E12",
              "CIE-10-CM-ES::E13",
              "CIE-10-CM-ES::E14"
            ]
          }
        }
      },
      "ICD-10-UK": {
        "id": "ICD-10-UK",
        "bindings": {
          "gt0201": {
            "codes": [
              "ICD-10-UK::N18",
              "ICD-10-UK::N19",
              "ICD-10-UK::I120",
              "ICD-10-UK::I131"
            ]
          },
          "gt0157": {
            "codes": [
              "ICD-10-UK::E10",
              "ICD-10-UK::E11",
              "ICD-10-UK::E12",
              "ICD-10-UK::E13",
              "ICD-10-UK::E14"
            ]
          }
        }
      },
      "READ2": {
        "id": "READ2",
        "bindings": {
          "gt0009": {
            "codes": [
              "READ2::46TC"
            ]
          },
          "gt0201": {
            "codes": [
              "READ2::1Z1",
              "READ2::K05"
            ]
          },
          "gt0157": {
            "codes": [
              "READ2::C10"
            ]
          },
          "gt0005": {
            "codes": [
              "READ2::451E"
            ]
          }
        }
      },
      "SNOMED-CT": {
        "id": "SNOMED-CT",
        "bindings": {
          "gt0157": {
            "codes": [
              "SNOMED-CT::73211009",
              "SNOMED-CT::46635009",
              "SNOMED-CT::44054006"
            ]
          },
          "gt0201": {
            "codes": [
              "SNOMED-CT::425369003",
              "SNOMED-CT::431855005",
              "SNOMED-CT::431856006",
              "SNOMED-CT::433144002",
              "SNOMED-CT::431857002",
              "SNOMED-CT::433146000"
            ]
          }
        }
      }
    }
  }
}
